Uyag, Theasal E.
HRN: 25-54-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/26/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/26/2024
08/02/2024
IV
300mg
Q6hrs
Mandibular Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes